INTRODUCTION
Transmissible spongiform encephalopathies (TSEs), commonly known as prion diseases, are fatal neurodegenerative disorders that affect both animals and humans (Collinge, 2001) . Prion diseases are characterized by the prominent accumulation of a misfolded prion protein, PrP Sc , in the central nervous system (Prusiner, 1991 (Prusiner, , 1998 . PrP Sc , which is rich in beta-sheet structures and resistant to digestion by proteases and various inactivating treatments (Caughey et al., 1991; Pan et al., 1993) , is considered to be the infectious agent for TSEs and appears to self-propagate through post-translational modification of the normal prion protein PrP C (Prusiner, 1998) .
One type of human prion disease, Creutzfeldt-Jakob disease (CJD), can be aetiologically identified as sporadic, inherited or acquired by infection (Ironside, 1998; Belay, 1999; Glatzel et al., 2002; Geissen et al., 2007) . In variant CJD (vCJD), which is a form of CJD caused by consumption of foods contaminated with bovine spongiform encephalopathy (BSE) prions Hill et al., 1997; Ironside, 2010) , small amounts of PrP Sc have been found in a broad range of peripheral tissues, including the lymph nodes, tonsils, spleen, kidneys, portions of the intestinal tract and skeletal muscle (Wadsworth et al., 2001; Hilton et al., 2004; Peden et al., 2006; Notari et al., 2010) , as well as in the central nervous system. These observations have led to serious concerns that the disease could spread in humans via blood transfusions (Wroe et al., 2006; Knight, 2010) and through the use of contaminated biological and surgical instruments. In order to effectively prevent the spread of this disease, it is important to be able to detect PrP Sc as soon after infection as possible, and then, it is crucial to avoid PrP Sc contamination in human-derived materials. As the concentration of PrP Sc in the tissues or body fluids of infected subjects is predicted to be extremely low until marked clinical signs appear, development of both a sensitive method for detecting PrP
Sc and animal models to confirm its validity are necessary.
Several studies have used non-human primates to study the transmissibility of human prion diseases (Gajdusek et al., 1966; Gibbs et al., 1968) , and the transmissibility of BSE has specifically been investigated using macaque monkeys (Lasmézas et al., 1996 (Lasmézas et al., , 2005 Comoy et al., 2008; Ono et al., 2011a, b) . These studies have reported a number of advantages of using non-human primate models of prion disease. For example, the pathological feature of florid plaques in the brain tissue of BSE-infected macaques and the biochemical characteristics of the PrP Sc glycoform profile in these macaques have been shown to be identical to those in human subjects with vCJD (Lasmézas et al., 1996) . In macaques inoculated with the BSE prion either intracerebrally or orally and in humans infected with vCJD, PrP Sc has been found to be distributed in various peripheral tissues, such as the lymph nodes, spleen, tonsils and muscles. These findings strongly support the possibility that vCJD is caused by an exogenous infection of a BSE prion. Furthermore, BSE can be transmitted via intravenous inoculation (Lasmézas et al., 2001) , indicating that macaques can serve as model animals for suspected cases of secondary transmission (via blood transfusion) of vCJD in humans. Therefore, nonhuman primate models are ideally suited for assessing methods for diagnosis and treatment of prion diseases.
In scrapie-infected rodents (Brown et al., 1998) and sheep (Houston et al., 2008) as well as in deer with chronic wasting disease (CWD), bodily fluids such as the blood, urine, saliva and faeces have been reported to be infectious (Mathiason et al., 2006; Haley et al., 2009b; Mathiason et al., 2010) . By using the protein misfolding cyclic amplification (PMCA) technique, which amplifies PrP Sc in vitro using normal brain homogenates as the PrP C substrate, PrP Sc has been detected in a variety of bodily fluids, including the blood, cerebrospinal fluid (CSF), urine, faeces, saliva and milk of prion-infected animals (Saborio et al., 2001; Saá et al., 2006; Murayama et al., 2007 Murayama et al., , 2010 ; Thorne & Terry, 2008; Terry et al., 2009; Maddison et al., 2009 Maddison et al., , 2010 Haley et al., 2009a Haley et al., , 2011 Tattum et al., 2010; Gough et al., 2012) . Furthermore, several reports have described the successful detection of PrP Sc in bodily fluids of humans with CJD (Orrú et al., 2009; Atarashi et al., 2011; Edgeworth et al., 2011; Peden et al., 2012; Rubenstein & Chang, 2013) . For example, PrP Sc in the CSF of patients with sporadic CJD (sCJD) and vCJD has been detected using the quaking-induced conversion technique (Atarashi et al., 2007) , which detects PrP Sc -triggered formation of amyloid fibrils of recombinant prion proteins. Similarly, PrP Sc has been detected in the CSF of patients with sCJD using PMCA followed by a sensitive immunoassay termed SOFIA (Rubenstein & Chang, 2013) , and bead-captured ELISA has been used to detect blood PrP Sc in patients with vCJD (Edgeworth et al., 2011) . Therefore, bodily fluids may have high utility as diagnostic materials for CJD. However, the quantitative changes of PrP Sc in bodily fluids of non-human primate models of CJD has not yet been determined due to a lack of sensitive methods for assessing very small amounts of prions in these animal models.
In the present study, we have developed a highly efficient PMCA method suitable for cynomolgus macaque BSE PrP Sc amplification. This method, which involves amplifying PrP Sc using xenogeneic (mouse) PrP C substrate in the presence of sulfated dextran compounds, is capable of amplifying a very small amount of PrP Sc from the CSF, blood, and peripheral tissue of BSE-infected macaques. We further investigated CSF and blood PrP Sc levels during the period from the latent to terminal stages of the disease and compared PrP Sc dynamics in macaques.
RESULTS

Amplification of cynomolgus macaque BSE PrP
Sc by PMCA
We first examined the amplification efficiency of PMCA, using the brain homogenate of BSE-infected cynomolgus macaque no. 7 as the PrP Sc seed. Before amplification, distinct signals of protease-resistant PrP (PrP res ) were detected in brain homogenates diluted up to 10 22 by Western blot analysis (Fig. 1a) . In the absence of potassium dextran sulfate (DSP), brain homogenates derived from the squirrel monkey and cynomolgus macaque were not suitable for amplification of cynomolgus PrP Sc (Fig. 1b, upper panel) . Similarly, no significant amplification was observed using cow, TgBoPrP and PrP 0/0 mice (Fig. 1b, middle panel) , or hamster brain homogenates (Fig. 1b, lower (Fig. 2b) . In addition, the generation of spontaneous PrP res , as has been reported for amplification in the presence of polyanions (Deleault et al., 2007; Wang et al., 2010) , was not observed in 16 samples that contained only mouse PrP C substrate following seven rounds of amplification (Fig. 2c) . 
PrP
Sc distribution in the peripheral tissues of BSE-affected macaques
We examined PrP
Sc distribution in macaques that were intracerebrally administered a brain homogenate prepared from a BSE-infected cow. In BSE-infected macaques, PrP Sc was detected by conventional Western blot analysis in several peripheral nervous tissues and lymph nodes (Table  S1 , available in the online Supplementary Material). By using serial PMCA, PrP
Sc was detected in all examined tissues, including: the peripheral nerves, lymph nodes, spleens, tonsils and adrenal glands (Fig. 3) . Most samples were found to be positive for PrP Sc after no more than two rounds of amplification. On the other hand, PrP Sc was detected after three rounds of amplification in four and two of the quadruplicate samples of the tonsil of macaque no. 10 ( Fig. 3b ) and spleen of macaque no. 11 (Fig. 3c) , respectively. No typical PrP res signal was detected in the peripheral nerves, lymph nodes, ileum and glands of an uninfected control macaque (Fig. S1 ).
PrP
Sc levels in the CSF
The amplification results for the CSF samples collected from the three macaques are illustrated in Fig. 4 . No typical PrP res signal was observed in samples that contained only after two rounds of amplification in macaque no. 10, which showed the shortest latent period of 828 days. On the other hand, the disease developed after a relatively longer latent period of over 1400 days in macaque no. 11, and PrP res signals were detected after four rounds of amplification in both samples collected upon dissection (1769 days p.i.).
PrP Sc levels in the blood
The results of the amplification of white blood cell (WBC) samples collected at several time points after intracerebral administration are illustrated in Fig. 5 . No typical PrP res signal was observed in samples that contained only mouse PrP C substrate (Fig. 5 , lanes Ns), or samples that contained normal macaque WBCs (10 4 cells) (Fig. 5 , no. 8C and Fig.  S2 ). Furthermore, we confirmed that the WBC matrix had no inhibitory effect on the amplification of PrP Sc by serial PMCA (Fig. S3) . In macaque no. 7, one of the quadruplicate samples collected upon dissection (1127 days p.i.) became positive for PrP Sc after five rounds of amplification. Similarly, PrP res signal was detected in one or both of the duplicate samples of macaque no. 11 collected at 1656 days p.i., and at dissection (1769 days p.i.). However, PrP Sc was not detected in the blood of these macaques between the latent and the initial stage of disease onset. In macaque no. 10, PrP res signal was not detected in the WBCs obtained during the experimental period (320-1067 days p.i.) even after seven rounds of amplification. With regard to plasma samples, no PrP Sc was detected in any of the samples collected during the experimental period (data not shown).
Infectivity of the PMCA product
The PMCA product obtained after ten rounds of amplification was diluted 10-fold and inoculated intracerebrally into tga20 mice. The tga20 mice inoculated with the PMCA products derived from the brain or WBC PrP Sc seeds died after an average period of 305 or 310 days, respectively (Table 1) . PrP Sc accumulation in the brains of mice was confirmed by Western blot analysis (data not shown). There was no significant difference between the survival periods of these PMCA product-inoculated mice (t-test, P.0.05). Control mice administered with the product containing only PrP C substrate survived more than 478 days. These results indicated that both brain-and WBC-derived PrP Sc had seeding activities following the PMCA reactions, and the amplified PrP Sc maintained their infectious ability during in vitro xenogeneic amplification.
DISCUSSION
In the current study, we developed an ultra-efficient PMCA technique for amplifying PrP Sc derived from BSE-infected cynomolgus macaques by using mouse brain homogenates with DSP as a PrP C substrate and a polyanion additive, respectively. We first proved the existence of PrP Sc in the CSF and blood of BSE-infected macaques by PMCA, and showed that cynomolgus macaque BSE PrP Sc , and non-macaque PrP C , effectively converted mouse PrP C to a proteinase K (PK)-resistant form. It is well known that PMCA of several xenogeneic combinations of PrP Sc seed and PrP C substrate can overcome the species barrier (Kurt et al., 2007 (Kurt et al., , 2011 Green et al., 2008; Castilla et al., 2008; Yoshioka et al., 2011; Murayama et al., 2012; Nemecek et al., 2013) , despite the divergent amino acid sequence of prion proteins. Since the BSE prion was transmissive to ICR (WT) mice (Masujin et al., 2008) , the cynomolgus macaque PrP Sc generated by the cross-species transmission of BSE prion may retain the original characteristics of BSE PrP Sc , including structural compatibility with mouse PrP C and DSP dependency in PMCA reactions.
PrP
Sc is detectable in the tonsil, spleen and lymph nodes in vCJD (Wadsworth et al., 2001 ) and sCJD patients (Rubenstein & Chang, 2013) . In an earlier study, PrP Sc was found in the lymphoid tissues, including: the lymph nodes, spleens and tonsils of macaques intracerebrally inoculated with BSE PrP Sc (Lasmézas et al., 1996) , as observed in vCJDinoculated macaques (Lasmézas et al., 2001) . Therefore, once PrP Sc accumulates in the brain, it may spread centrifugally from the brain to the peripheral tissues through the autonomic nervous system. However, in our previous study, we failed to detect PrP Sc in such lymphoid tissues of the BSE-inoculated macaques by conventional Western blotting, except in the submandibular lymph nodes, deep cervical lymph nodes and inguinal lymph nodes (Ono et al., 2011a;  Table S1 ). In the current study, PMCA analysis revealed that PrP Sc was distributed in all lymphoid tissues examined in the BSE-infected macaques.
Sc levels in most of the lymphoid tissues were extremely low, because PrP Sc could only be detected after two or three rounds of amplification. Therefore, significant PrP Sc accumulation in the peripheral non-neuronal tissues might not have occurred in these macaques, and PrP Sc levels in most lymphoid tissues might have been below the detection limit of the conventional Western blot technique used herein, even at the terminal stage of the disease. The origin of PrP Sc in WBCs may be the spleen and other lymphoid organs, as suggested previously (Saá et al., 2006) . As in humans, PrP C is constitutively expressed in the WBCs of cynomolgus macaques (Holada et al., 2007) ; therefore, WBCs of cynomolgus macaques can be deemed carriers or reservoirs of PrP Sc . Our finding supports the idea that prion diseases may be transmitted via infected blood in primates, as has been previously seen in scrapie-infected sheep (Houston et al., 2008) and CWD-infected deer (Mathiason et al., 2006) . An illustration for the appearance of PrP Sc in the CSF and WBCs of intracerebrally infected macaques is shown in Fig. 6 . PrP Sc was found in the WBCs at clinical stages of the disease in macaques no. 7 and no. 11, but PrP Sc was not detected in the WBCs of macaque no. 10 throughout the experimental period. Survival time of the BSEinfected macaques ranged from 1067 days to 1769 days. During the period from the onset of clinical signs to the terminal stage of the disease, PrP Sc was detected in the CSF in all three BSE-infected macaques. The highest level of PrP Sc in the CSF collected upon dissection was observed in macaque no. 10.
A previous study showed that elevated levels of 14-3-3 proteins, which are widely distributed in eukaryotes and play an important role in various signal transduction systems involved in cell proliferation and division, were observed in the CSF of a simian vCJD model (Yutzy et al., 2007) . The increase of PrP Sc in the CSF probably reflects the leakage of PrP Sc from neuronal cells after cell destruction caused by PrP Sc infection. We examined 14-3-3 c levels in the CSF of the BSE-infected macaques (Fig. S4) , and found that the signal intensity of the 14-3-3 c protein became notable after disease onset (no. 7 and no. 10), or in the latter stages of the disease (no. 11). It is worth noting that the highest levels of the 14-3-3 c protein were observed in the CSF of macaque no. 10 collected at dissection. Therefore, the disease might have progressed most rapidly after a shorter latent period (829 days) in macaque no. 10 than in macaques no. 7 (867 days) and no. 11 (1439 days). Faster accumulation of PrP Sc in the brain may cause acute brain damage and result in death before a significant number of infected WBCs begin circulating in the peripheral blood. Macaques no. 7 and 10 both belonged to a breeding colony introduced from the Philippines, and no. 11 was derived from a Malaysian lineage. Thus, the different degrees of disease progression might be related to genetic factors affecting susceptibility or resistance to prion infection. More detailed studies are needed to clarify the above possibility.
In conclusion, we have developed a highly sensitive method that enables a detailed and precise examination of the distribution of PrP Sc throughout the bodies of BSE-infected macaques. We are now conducting experiments analysing oral transmission of the BSE prion and transmission through blood transfusions from BSE-infected macaques. Using our method, PrP Sc could notably be detected in bodily fluids obtained during the latent period of the disease in both primate models. Thus, the method developed in this study may be useful in furthering the understanding of tissue distribution of PrP Sc in non-human primate models of CJD.
METHODS
BSE-infected macaques. This study on non-human primates was conducted according to the rules for animal care and management of the Tsukuba Primate Research Center (Honjo, 1985) and the guiding principles for animal experiments using non-human primates formulated by the Primate Society of Japan (Primate Society of Japan, 1986). The cynomolgus macaques (Macaca fascicularis) examined in this study originated from the Philippines (no. 7 and 10) or Malaysia (no. 11), and were bred at Tsukuba Primate Research Center of the National Institute of Biomedical Innovation. Transmission experiments were approved by the Animal Welfare and Animal Care and Use Committee (approval ID: DS18-069R1) and Animal Ethics Biosafety Committee (approval ID: BSL3-R-06.01) of the National Institute of Biomedical Innovation. The brain homogenate (200 ml of a 10 % brain homogenate) derived from a classical BSE (c-BSE)-infected 83-month-old Holstein (Iwata et al., 2006) was intracerebrally administered to three male macaques (no. 7, 10 and 11) that were 24-29 months in age (Ono et al., 2011a) . The animals were housed in biosafety level three animal rooms, and their clinical status was monitored daily. After 35-59 months, the animals were euthanized by anaesthesia overdose following evidence of progressive neurological dysfunction, after which the animals were dissected. A healthy macaque (no. 8 or 28) was used as an uninfected control in the PMCA assay of tissues and bodily fluids. All macaques examined in this study were homozygous for methionine at codon 129 (MM) and homozygous for glutamic acid at codon 219 (EE).
Sample preparation. Peripheral nervous and lymphoid tissues were collected upon dissection and stored in small aliquots at 280 uC. Samples from each tissue were homogenized at 10 % (w/v) in PBS. WBCs, plasma and CSF were also collected at several time points after inoculation. The blood samples (1.5 ml) were centrifuged at 1500 g for 15 min and the plasma and buffy coat fractions were recovered. Erythrocytes contaminated in the buffy coat fraction were haemolysed in distilled water, and the samples were stored at 280 uC until analysis.
Preparation of PrP C substrates. To avoid contamination, normal brain homogenates were prepared in a laboratory in which infected materials had never been handled. Brains of a healthy cynomolgus macaque, squirrel monkey (Saimiri sciureus), cow, PrP C -overexpressing transgenic [Tg(BoPrP) 4092HOZ/Prnp 0/0 , TgBoPrP] mouse (Scott et al., 1997) , PrP-knockout (PrP 0/0 ) mouse, WT mouse (ICR), and Syrian hamster were homogenized at a 20 % (w/v) concentration in PBS containing a complete protease inhibitor cocktail (Roche Diagnostics). The brain homogenates were stored at 280 uC until further use. For analysis, the homogenates were mixed with an equal volume of the elution buffer (PBS containing 2 % Triton X-100, 8 mM EDTA) and incubated at 4 uC for 1 h with continuous agitation. After centrifugation at 4500 g for 5 min, the supernatant was used as the PrP C substrate. When using brain homogenates of TgBoPrP mice, the supernatants were mixed in a 5 : 1 proportion of PrP 0/0 :TgBoPrP, and this mixture was used as the PrP C substrate.
PMCA. For the amplification of brain PrP Sc , the BSE-infected brain homogenate of macaque no. 7 was diluted from 10 23 to 10 25 with normal brain homogenates from several animal species in an electron beam-irradiated polystyrene tube (total volume, 100 ml). Amplification was performed in the presence or absence of 1 % (w/v) DSP, which has been shown to markedly improve in vitro amplification efficiency of bovine BSE PrP Sc (Murayama et al., 2010) . Amplification was carried out with a fully automatic cross-ultrasonic protein activating apparatus (Elestein 070-CPR; Elekon Science Corporation), which had the capacity to generate high ultrasonic power (700 W). PMCA was performed by 40 cycles of sonication in which a 3 s pulse oscillation was repeated five times at 1 s intervals, followed by incubation at 37 uC for 1 h with agitation.
To examine the sensitivity of interspecies PMCA using the mouse PrP C substrate for the detection of macaque BSE PrP Sc , the 10 % infected brain homogenate was serially diluted from 10 23 to 10
212
with mouse PrP C substrate containing 1 % (w/v) DSP (total volume, 80 ml) in an electron beam-irradiated eight-strip polystyrene tube specially designed for PrP Sc propagation (Murayama et al., 2010) . To obtain maximum amplification efficiency and reduce non-specific background signal in Western blot analysis, a series of amplification steps were programmed as follows: PMCA was performed with 40 cycles of sonication in which a 15 s oscillation and subsequent incubations at 31 uC for 1 h were repeated 10 times; a 15 s oscillation and subsequent incubations at 33 uC for 1 h were repeated 10 times; an intermittent oscillation (3 s pulse oscillation was repeated five times at 1 s intervals) and subsequent incubations at 35 uC for 1 h were repeated 10 times; and finally intermittent oscillations (3 s pulse oscillation was repeated five times at 1 s intervals) and subsequent incubation at 37 uC for 1 h were repeated 10 times. The amplified product obtained after the first round of amplification was diluted 1 : 5 with the PrP C substrate, and a second round of amplification was performed. This process was repeated for a maximum of six times.
For amplifying PrP
Sc in various tissues from BSE-inoculated macaques, the mouse PrP C substrate containing 1 % (w/v) DSP was mixed with a 1/10 volume of homogenized samples or bodily fluids (total volume 80 ml) in eight-strip polystyrene tubes. The WBC pellet (approx. 10 4 cells) was dissolved in 8 ml of the elution buffer and used as a seed. Serial PMCA was then performed using the four-step amplification programme as described above.
Western blotting. After each round of amplification, samples of 10 ml were mixed with 10 ml of PK solution (100 mg PK ml 21 ) and incubated at 37 uC for 1 h. The digested materials were mixed with 20 ml of 26 SDS sample buffer and incubated at 100 uC for 5 min. The samples were separated by SDS-PAGE and transferred onto a PVDF membrane (Millipore). After blocking, the membrane was incubated for 1 h with HRP-conjugated T2 mAb (Hayashi et al., 2004; Shimizu et al., 2010) at a 1 : 10 000 dilution. The T2 antibody, which recognizes a discontinuous epitope in amino acid residues 132-156 in the mouse PrP sequence, also reacts with hamster and monkey PrP. After washing, the blotted membrane was developed with Immobilon Western Chemiluminescent HRP Substrate (Millipore), according to the manufacturer's instructions. Chemiluminescence signals were analysed with the Light Capture system (ATTO). On: Mon, 07 Jan 2019 00:08:49 and its subsequent amplification was repeated nine times. The product from the tenth round was diluted 1 : 10 with PBS and inoculated intracerebrally (20 ml per mouse) into tga20 mice (Fischer et al., 1996) that overexpress mouse PrP C . Infectivity of the PMCA product from the tenth round of amplification of a PrP Sc -positive WBC sample from macaque no. 7 obtained at dissection 1127 days p.i. was also examined. The PMCA product from the tenth round of amplification of no-seed sample was inoculated as negative control. In addition to the PMCA products, 10 % brain homogenate of a c-BSE infected cow was also inoculated into tga20 mice to compare infectivity. The bioassay experiments were approved by the Animal Care and Use Committee of the National Institute of Animal Health (approval ID: 09-44) and were conducted in accordance with the guidelines for animal transmissible spongiform encephalopathy experiments of the Ministry of Agriculture, Forestry and Fisheries of Japan.
